Genetically engineered T cells to target EGFRvIII expressing glioblastoma.
Bullain SS, Sahin A, Szentirmai O, Sanchez C, Lin N, Baratta E, Waterman P, Weissleder R, Mulligan RC, Carter BS.
Bullain SS, et al. Among authors: baratta e.
J Neurooncol. 2009 Sep;94(3):373-82. doi: 10.1007/s11060-009-9889-1. Epub 2009 Apr 23.
J Neurooncol. 2009.
PMID: 19387557
Free PMC article.